ClinicalTrials.Veeva

Menu

The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection

S

Sisli Hamidiye Etfal Training and Research Hospital

Status

Completed

Conditions

Covid19
Smoking

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a retrospective single centered study that was done in the ICU on patients with Covid-19 between 16th of March -16th of May in 2020 Retrospective records will be examined by examining the electronic data files of the patients.

There were two groups as smoker and non-smoker.

Full description

The aims of the present study is to see the effects of smoking prevalence, the length of stay regarding the usage of cigarettes, and the effects on the mortality of COVID-19 in our intensive care unit(ICU).

This is a retrospective single centered study that was done in the ICU on patients with Covid-19 between 16th of March -16th of May in 2020. The demographic data, comorbidity status, the units they were accepted from, clinical symptoms , respiratory support, prevalence of smoking, length of stay in the ICU and mortalities of the patients weill be recorded. There are two groups as smoker and non-smoker.

Enrollment

150 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All the patient's data are diagnosed with acute respiratory syndrome Covid-19 over 18 years old

Exclusion criteria

  • Patients under 18 years of age

Trial design

150 participants in 2 patient groups

smoker
Description:
active smokers
Treatment:
Other: no intervention
non-smoker
Description:
Patients who have never smoked
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems